Home Cart 0 Sign in  
X

[ CAS No. 50-85-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 50-85-1
Chemical Structure| 50-85-1
Chemical Structure| 50-85-1
Structure of 50-85-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 50-85-1 ]

Related Doc. of [ 50-85-1 ]

Alternatived Products of [ 50-85-1 ]

Product Details of [ 50-85-1 ]

CAS No. :50-85-1 MDL No. :MFCD00002454
Formula : C8H8O3 Boiling Point : -
Linear Structure Formula :- InChI Key :NJESAXZANHETJV-UHFFFAOYSA-N
M.W : 152.15 Pubchem ID :5788
Synonyms :
m-Cresotic acid;2-Hydroxy-4-methylbenzoic acid;2-Hydroxy-p-toluic acid;m-Cresotinic acid

Calculated chemistry of [ 50-85-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 40.39
TPSA : 57.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.42
Log Po/w (XLOGP3) : 2.99
Log Po/w (WLOGP) : 1.4
Log Po/w (MLOGP) : 1.32
Log Po/w (SILICOS-IT) : 1.19
Consensus Log Po/w : 1.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.0
Solubility : 0.151 mg/ml ; 0.000989 mol/l
Class : Soluble
Log S (Ali) : -3.86
Solubility : 0.0209 mg/ml ; 0.000137 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.57
Solubility : 4.13 mg/ml ; 0.0272 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.02

Safety of [ 50-85-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 50-85-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 50-85-1 ]
  • Downstream synthetic route of [ 50-85-1 ]

[ 50-85-1 ] Synthesis Path-Upstream   1~29

  • 1
  • [ 50-85-1 ]
  • [ 66571-26-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 24, p. 8541 - 8554
[2] Tetrahedron Letters, 2016, vol. 57, # 48, p. 5301 - 5303
  • 2
  • [ 50-85-1 ]
  • [ 182500-28-3 ]
Reference: [1] Journal of the Chemical Society, 1914, vol. 105, p. 1891
  • 3
  • [ 50-85-1 ]
  • [ 39503-58-7 ]
Reference: [1] Patent: WO2012/28629, 2012, A1,
[2] Patent: US2018/127370, 2018, A1,
  • 4
  • [ 50-85-1 ]
  • [ 77-78-1 ]
  • [ 81245-24-1 ]
YieldReaction ConditionsOperation in experiment
96%
Stage #1: With potassium carbonate In acetone for 14 h; Heating / reflux
Stage #2: With ammonia In methanol; water at 20℃; for 0.5 h;
Methyl 5-bromo-4-carboxymethyl-2-methoxybenzoate was synthesized according tothe method described in WO 01/35900. A 1 L 3-neck RBF, fitted with a droppingfunnel, a condenser and a magnetic stirring bar was charged with 4-methylsalicylicacid 10a (50 g, 0.33 mol), K2CO3 (91.1 g, 0.66 mol, 2 eq) and dry acetone (500 ml).This mixture was heated under reflux while dimethylsulfate (112.3 g, 0.891 mol, 2.7eq) was added dropwise. The reaction mixture was refluxed for -14 h (TLCindicated that the reaction was completed). The inorganic salts were filtered off andthe THF filtrate was evaporated under reduced pressure to obtain a yellow oil. Thisresidue was dissolved in 400 ml_ MeOH and a solution of cone. NH4OH (115 ml_)was added. The resulting mixture was stirred at RT for 30 min. The MeOH wasthen distilled off and the residue was diluted with water (500 ml_) and the oilyproduct was extracted with diethyl ether (3X300 mL). The combined organicextracts were dried over sodium sulfate and the diethyl ether was removed undervacuum to give pure methyl 2-methoxy-4-methylbenzoate 10b as a yellow oil (57 g,96percent yield). A dry 2 L 3-neck RBF fitted with an argon inlet, a thermometer, a magnetic stirringbar and a septum was charged with THF (220 mL) and diisopropylamine (54.6 mL,0.39 mol, 1.2 eq). The resulting mixture was cooled to -50°C and a solution of 2.5 Mn-BuLi (156 mL, 0.39 mol, 1.2 eq) was added slowly via cannula. After 30 min ofstirring at -50°C, the solution of LDA generated was cooled to -78°C and HMPA(67.8 mL, 0.39 mol, 1.2 eq) was added, followed by a solution of methyl 2-methoxy-4-methylbenzoate 10b (57 g, 0.32 mol) in THF (220 ml), while maintaining thetemperature at -78°C. The reaction mixture was stirred two more hours at -78°C,and then cannulated into a flask containing 100 g dry ice and THF (200 ml). After30 min stirring at -78°C, the reaction mixture was allowed to warm up slowly to RTand then poured into water (1.5 L). The organic layer was separated and theaqueous layer was further extracted with ether (3X1 L). The water layer wasacidified with a solution of 10percent H2SO4 (150 ml) and the reaction product wasextracted into CH2CI2 (3X1.5 L). The combined organic extracts were dried overanhydrous Na2SO4, the solvent was removed under reduced pressure and the crudeproduct was purified by flash chromatography (eluent EtOAc: hexane 3:7), followedby recrystallization from CH2CI2:hexane 1:1 to afford pure methyl 4-carboxymethyl-2-methoxybenzoate 10c (38.8 g, 54.7percent yield). Methyl 4-cafboxymethyl-2-methoxybenzoate 10c (12.7g, 0.0567 mol) was dissolved in glacial AcOH (100 ml_) and bromine (3.2 ml, 0.0624 mol, 1.1 eq) was added drop wise via a syringe, while maintaining the internal temperature between 20-25°C.iAfter stirring for 4 h at RT, the AcOH was evaporated and the orange oil co-evaporated twice with toluene to give an orange solid. This material was trituratedwith CH2CI2and some of the precipitated product was removed by filtration. The restof the product which remained in the filtrate was then concentrated, loaded on asilica gel column and eluted with 1percent AcOH in EtOAc:hexane (6:4 ratio). Theproduct was further purified by a second chromatography and re-crystallization fromEtOAc:hexane to give pure methyl 5-bromo-4-carboxymethyl-2-methoxybenzoate aswhite solid 10d (total amount 9 g, 52percent yield).
Reference: [1] Patent: WO2004/108673, 2004, A2, . Location in patent: Page 45-46
[2] Bioorganic and medicinal chemistry, 2002, vol. 10, # 9, p. 3013 - 3021
[3] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2334 - 2356
[4] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 19, p. 4987 - 4993
[5] Patent: WO2004/65367, 2004, A1, . Location in patent: Page 152 - 153; 157
  • 5
  • [ 50-85-1 ]
  • [ 74-88-4 ]
  • [ 81245-24-1 ]
YieldReaction ConditionsOperation in experiment
91% With potassium carbonate In DMF (N,N-dimethyl-formamide) for 18 h; To a mixture of 2-hydroxy-4-methylbenzoic acid(30.43 g, 200 mmol) , K2CC>3 (62.19 g, 450 mmol) and DMF(600 mL) was added methyl iodide (28.01 mL, 450 mmol). Thereaction was stirred for 18 h, poured into ice/water(1.2 L), and extracted with EtOAc (2 X 300 mL). Thecombined organic layer was washed with brine, satd NaHCC>3and dried (MgSC>4) . The resulting solution was concentratedand distilled to give the title compound as a pale yellowliquid (32.73 g, 91percent, bp 120-4 °C/1333 Pa, 10 mm).(400MHz, CDCls): 5 2.40 (s, 3H), 3.90 (s, 3H), 3.93 (s,3H), 6.80 (m, 2H), 7.75 (d, J = 7.6 Hz, 1H).FIA-MS, m/e: 180.9 (m+1).
10 g
Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 1 h;
Stage #2: at 60℃; for 18 h;
To a solution of 2-hydroxy-4-methylbenzoic acid (10.00 g, 65 mmol) in DMF (10 mL) was added K2CO3 (13.6 g, 98 mmol). The reaction mixture was stirred at 60°C for 1 h. Methyl iodide (14.0 g, 98 mmol) was added to the reaction mixture and was stirred at 60°C for 18 h. The reaction mass was quenched in water and concentrated. The reaction mass was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulphate and concentrated to afford 10.00 g of desired product. 1H NMR (300 MHz, DMSO d6): δ 2.34 (s, 3H), 3.74 (s, 3H), 3.79 (s, 3H), 6.81 (d, J = 7.2 Hz, 1H), 6.97 (s, 1H), 7.56 (d, J = 7.8 Hz, 1H); MS (m/z): 180.95 (M+H)+.
11.0 g With potassium carbonate In N,N-dimethyl-formamide at 20℃; To a mixture of 2-hydroxy-4-methylbenzoic acid (10.0 g, 65.7 mmol) and K2CO3 (22.7 g, 164.3 mmol) in DMF (200 mL) at room temperature was added methyl iodide (20.5 g, 144.5 mmol) over a period of 10 minutes. The resulting mixture was stirred at room temperature overnight, then diluted with DCM (150 mL) and filtered. The filtrate was washed with water (200 mL x 10) and brine (200 mL x 2), dried a2S04) and concentrated to give the intermediate as a yellow liquid (1 1.0 g)
Reference: [1] Patent: WO2004/108677, 2004, A1, . Location in patent: Page 198-199
[2] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 2, p. 185 - 190
[3] Journal of Medicinal Chemistry, 1992, vol. 35, # 4, p. 734 - 740
[4] Patent: US5302601, 1994, A,
[5] Patent: EP2119718, 2009, A1, . Location in patent: Page/Page column 33-34
[6] Patent: EP2133353, 2009, A1, . Location in patent: Page/Page column 54-55
[7] Patent: WO2012/28629, 2012, A1, . Location in patent: Page/Page column 39
[8] Patent: US8148536, 2012, B2, . Location in patent: Page/Page column 72
[9] Organic Letters, 2012, vol. 14, # 19, p. 5102 - 5105,4
[10] Journal of Medicinal Chemistry, 2012, vol. 55, # 19, p. 8524 - 8537,14
[11] Patent: WO2013/186692, 2013, A1, . Location in patent: Page/Page column 107
[12] Patent: WO2016/34673, 2016, A1, . Location in patent: Page/Page column 116
[13] Patent: EP2272835, 2011, A1, . Location in patent: Page/Page column 19
  • 6
  • [ 50-85-1 ]
  • [ 67-64-1 ]
  • [ 81245-24-1 ]
YieldReaction ConditionsOperation in experiment
98% With potassium carbonate In dimethyl sulfoxide at 20℃; for 19 h; Reflux To a solution of 4-methylsalicylic acid (2.93 g, 19.1 mmol, 1 equiv) in acetone (34.8 mL) wasadded finely ground K2C03 (7.9 g, 57.2 mmol, 3 equiv) and Me2SO4 (5.42 mL, 57.2 mmol, 3equiv). The solution was stirred at rt for 18 h and under reflux for 1 h. The reaction mixture was filtered and concentrated under reduced pressure. The crude residue was dissolved in EtOAc (100 mL) and Et3N (2.65 mL, 19.1 mmol, 1 equiv) was added. The reaction mixture was stirred at rt for 30 mm. The reaction mixture was successively washed with water, 2N HC1, and brine.The organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel column (hexane/EtOAc 10:0 to 10:10 (v/v) in 30 mm) to afford a colorless liquid (3.37 g, 18.7 mmol, 98 percent).HPLC Purity = 99percent; tr = 4.02 mm; ‘H NMR (400 MHz, CDC13) ö 7.73 (d, J8.4 Hz, 1H),6.80-6.78 (m, 2H), 3.90 (s, 3H), 3.87 (s, 3H), 2.39 (s, 3H); ‘3C NMR (101 MHz, CDC13) ö166.6, 159.3, 144.6, 131.8, 120.9, 116.9, 112.8, 55.9, 51.8, 21.9; MS (ESIj: mlz = 203[M+Na].
Reference: [1] Patent: WO2018/11376, 2018, A1, . Location in patent: Page/Page column 52
  • 7
  • [ 50-85-1 ]
  • [ 81245-24-1 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1997, # 1, p. 228 - 240
[2] Patent: WO2015/120390, 2015, A1,
  • 8
  • [ 50-85-1 ]
  • [ 77-78-1 ]
  • [ 81245-24-1 ]
  • [ 704-45-0 ]
Reference: [1] Journal of the Chemical Society, 1906, vol. 89, p. 1655
  • 9
  • [ 50-85-1 ]
  • [ 39503-57-6 ]
Reference: [1] Patent: WO2012/28629, 2012, A1,
[2] Patent: WO2015/163485, 2015, A1,
[3] Patent: WO2016/208775, 2016, A1,
[4] Patent: WO2018/24224, 2018, A1,
  • 10
  • [ 50-85-1 ]
  • [ 4670-56-8 ]
YieldReaction ConditionsOperation in experiment
90% With sulfuric acid In methanol; ethyl acetate Example VI
Preparation of N-Hydroxysuccinimidyl 3-(N-[3-hydroxy-4-(methoxycarbonyl)phenyl]methyl}carbamoyl)propionate STR24 Methyl 4-Methyl-2-hydroxybenzoate
4-Methyl-2-hydroxybenzoic acid (100 g, 658 mmoles) was dissolved in anhydrous methanol (500 mL) and concentrated sulfuric acid (25 mL) was added carefully.
The solution was refluxed for 18 hours, then cooled to room temperature.
The reaction mixture was concentrated to about 150 mL, and ethyl acetate (250 mL) was added.
The ethyl acetate solution was washed twice with saturated aqueous sodium bicarbonate (250 mL portions) and then with saturated aqueous sodium chloride (100 mL).
The ethyl acetate solution was dried over anhydrous sodium sulfate, filtered, and evaporated to a clear, reddish-brown liquid.
This crude product was vacuum distilled (oil pump) to afford a clear, viscous liquid that solidified on standing to afford 98.1 g (90percent yield) of methyl 4-methyl-2-hydroxybenzoate.
1 H NMR (300 MHz, CHCl3 -d) δ 2.32 (singlet, 3H, ArCH3), 3.91 (singlet, 3H, OCH3), 6.67 (doublet, J=8 Hz, 1H, ArH), 6.78 (singlet, 1H, ArH), 7.69 (doublet, J=8 Hz, 1H, ArH), 10.71 (singlet, 1H, OH).
13 C NMR (75 MHz, CHCl3 d) δ 21.8, 52.1, 110.0, 117.9, 120.6, 129.9, 147.3, 161.9, 170.9.
90% With sulfuric acid In methanol; ethyl acetate EXAMPLE IV
Preparation of a Reagent of General Formula I Methyl 4-Succinylaminomethylsalicylate Succinimidyl Ester STR21 Methyl 4-Methylsalicylate
4-Methylsalicylic acid (100 g, 658 mmoles) was dissolved in anhydrous methanol (500 mL) and concentrated sulfuric acid (25 mL) was added carefully.
The solution was refluxed for 18 hours, then cooled to room temperature.
The reaction mixture was concentrated to about 150 mL, and ethyl acetate (250 mL) was added.
The ethyl acetate solution was washed twice with saturated aqueous sodium bicarbonate (250 mL portions) and then with saturated aqueous sodium chloride (100 mL).
The ethyl acetate solution was dried over anhydrous sodium sulfate, filtered, and evaporated to a clear, reddish-brown liquid.
This crude product was vacuum distilled (oil pump) to afford a clear, viscous liquid that solidified on standing to afford 98.1 g (90percent yield) of methyl 4-methylsalicylate.
1 H NMR (300 MHz, CHCl3 -d) δ2.32 (singlet, 3H, ArCH3), 3.91 (singlet, 3H, OCH3), 6.67 (doublet, J=8 Hz, 1H, ArH), 6.78 (singlet, 1H, ArH), 7.69 (doublet, J=8 Hz, 1H, ArH), 10.71 (singlet, 1H, OH).
13 C NMR (75 MHz, CHCl3 -d) δ21.8, 52.1, 110.0, 117.9, 120.6, 129.9, 147.3, 161.9, 170.9.
90% With sulfuric acid In methanol; ethyl acetate Methyl 4-Methylsalicylate
4-Methylsalicylic acid (100 g, 658 mmoles) was dissolved in anhydrous methanol (500 mL) and concentrated sulfuric acid (25 mL) was added carefully.
The solution was refluxed for 18 hours, then cooled to room temperature.
The reaction mixture was concentrated to about 150 mL, and ethyl acetate (250 mL) was added.
The ethyl acetate solution was washed twice with saturated aqueous sodium bicarbonate (250 mL portions) and then with saturated aqueous sodium chloride (100 mL).
The ethyl acetate solution was dried over anhydrous sodium sulfate, filtered, and evaporated to a clear, reddish-brown liquid.
This crude product was vacuum distilled (oil pump) to afford a clear, viscous liquid that solidified on standing to afford 98.1 g (90percent yield) of methyl 4-methylsalicylate.
1 H NMR (300 MHz, CHCl3- d) δ2.32 (singlet, 3H, ArCH3), 3.91 (singlet, 3H, OCH3), 6.67 (doublet,J=8 Hz, 1H, ArH), 6.78 (singlet, 1H, ArH), 7.69 (doublet, J=8 Hz, 1H, ArH), 10.71 (singlet, 1H, OH).
13 C NMR (75 MHz, CHCl3- d) δ21.8, 52.1, 110.0, 117.9, 120.6, 129.9, 147.3, 161.9, 170.9.
90% With sulfuric acid In methanol; ethyl acetate EXAMPLE IV
Preparation of a Reagent of General Formula I Methyl 4-Succinylaminomethylsalicylate Succinimidyl Ester STR21 Methyl 4-Methylsalicylate.
4-Methylsalicylic acid (100 g, 658 mmoles) was dissolved in anhydrous methanol (500 mL) and concentrated sulfuric acid (25 mL) was added carefully.
The solution was refluxed for 18 hours, then cooled to room temperature.
The reaction mixture was concentrated to about 150 mL, and ethyl acetate (250 mL) was added.
The ethyl acetate solution was washed twice with saturated aqueous sodium bicarbonate (250 mL portions) and then with saturated aqueous sodium chloride (100 mL).
The ethyl acetate solution was dried over anhydrous sodium sulfate, filtered, and evaporated to a clear, reddish-brown liquid.
This crude product was vacuum distilled (oil pump) to afford a clear, viscous liquid that solidified on standing to afford 98.1 g (90percent yield) of methyl 4-methylsalicylate.
1 H NMR (300 MHz, CHCl3-d) δ 2.32 (singlet, 3H, ArCH3), 3.91 (singlet, 3H, OCH3), 6.67 (doublet, J=8 Hz, 1H, ArH), 6.78 (singlet, 1H, ArH), 7.69 (doublet, J=8 Hz, 1H, ArH), 10.71 (singlet, 1H, OH).
13 C NMR (75 MHz, CHCl3-d) δ 21.8, 52.1, 110.0, 117.9, 120.6, 129.9, 147.3, 161.9, 170.9.

Reference: [1] Patent: US6156884, 2000, A,
[2] Patent: US5777148, 1998, A,
[3] Patent: US5837878, 1998, A,
[4] Patent: US5847192, 1998, A,
[5] Patent: US2003/219780, 2003, A1,
[6] Patent: US6150413, 2000, A,
[7] Patent: US2018/346438, 2018, A1,
  • 11
  • [ 67-56-1 ]
  • [ 50-85-1 ]
  • [ 4670-56-8 ]
YieldReaction ConditionsOperation in experiment
95% at 0℃; Inert atmosphere; Reflux SOCl2 (10.9 mL, 150 mmol) was added dropwise into a solution of 193 4-methylsalicylic acid (5.0 g, 32.9 mmol, TCI reagent) in 27 MeOH (80 mL) at 0°C in a nitrogen atmosphere. A resulting mixture was stirred at reflux overnight. After a reaction was completed, a volatile solvent was evaporated under reduced pressure. A resulting residue was purified by means of a silica gel column chromatography, so as to obtain the 194 title compound (30-1) (5.18 g, 31.2 mmol, 95percent). (0238) 1H NMR (400 MHz, CDCl3); δ 10.70 (s, 1H), 7.71 (d, J = 8.0 Hz, 1H), 6.79 (s, 1H), 6.69 (d, J = 8.4 Hz, 1H), 3.93 (s, 3H), 2.34 (s, 3H)
94% at 20℃; for 5.5 h; Reflux 1 3A. Methyl 2-hydroxy-4-methyl-benzoateConcentrated H2504 (200 mL) was added dropwise over 30 minutes to a stirredsolution of 2-hydroxy-4-methyl-benzoic acid (100 g, 657 mmol) in MeOH (500 mL) at room temperature. The mixture was heated to reflux for 5 hours then allowed to cool to room temperature and carefully poured into ice cold saturated NaHCO3 solution(300 mL). The mixture was extracted with DCM (4 x 500 mL) and the combinedorganic extracts dried (Na2504) and evaporated under reduced pressure to give thetitle compound (100 g, 94percent) which was used without further purification.
84.6% Reflux General procedure: A mixture of organic acid (0.5 g) and methanol (100 ml) was heated under reflux in presence of sulphuric acid (0.8 ml) until the completion of the reaction which was checked by single spot TLC. Then, methanol was removed under reduced pressure a half and the solution was diluted with 20 ml of water. The product was extracted with ethyl acetate (30 ml). The organic phase was neutralized successively with NaHCO3 5percentand water, dried over anhydrous Na2SO4, and filtered. The ethyl acetate phase was separated, which on evaporation yielded the ester derivatives
72% at 0 - 20℃; for 5 h; Heating / reflux A 50 ml round-bottom flask equipped with a stir bar under a dry nitrogen atmosphere was charged with 4-methylsalicylic acid (1.5 g, 10.0 mmoles, 1.0 eq) followed by dry MeOH (15 ml). The reaction mixture was cooled to 0° C. on an ice bath and neat SOCl2 (1.1 ml, 15.0 mmoles, 1.5 eq) was added dropwise. The reaction was allowed to warm to room temperature and then stirred at reflux for 5 hrs. After that time, excess MeOH was removed in vacuo, the residue dissolved in EtOAc and extracted with saturated NaHCO3, the organic layer was dried with MgSO4 and filtered. Removal of excess solvent from the filtrate in vacuo provided 1.20 g (72percent) of the title compound as a clear oil. (1H CDCl3, 400 MHz): δ 10.71 (s, 1H), 7.70 (d, J=8.1 Hz, 1H), 6.75 (s, 1H), 6.69 (d, J=8.1 Hz, 1H), 3.93 (s, 3H), 2.34 (s, 3H).

Reference: [1] Journal of the American Chemical Society, 2006, vol. 128, # 36, p. 11940 - 11947
[2] Journal of the Chemical Society - Series Chemical Communications, 1989, # 3, p. 186 - 187
[3] Patent: EP3404033, 2018, A1, . Location in patent: Paragraph 0237-0238
[4] Patent: WO2015/120390, 2015, A1, . Location in patent: Page/Page column 92; 138
[5] Organic and Biomolecular Chemistry, 2015, vol. 13, # 43, p. 10745 - 10750
[6] Journal of the American Chemical Society, 1994, vol. 116, # 6, p. 2629 - 2630
[7] Natural Product Research, 2018, vol. 32, # 5, p. 572 - 575
[8] Patent: US2005/143434, 2005, A1, . Location in patent: Page/Page column 9
[9] Chemische Berichte, 1890, vol. 23, p. 2953
[10] Bulletin de la Societe Chimique de France, 1908, vol. <4> 3, p. 730[11] Bulletin de la Societe Chimique de France, 1910, vol. <4> 7, p. 332
[12] Bioorganic and Medicinal Chemistry, 2000, vol. 8, # 1, p. 73 - 93
[13] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 2, p. 171 - 175
[14] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 24, p. 8618 - 8629
[15] European Journal of Medicinal Chemistry, 2012, vol. 47, # 1, p. 473 - 478
[16] Patent: WO2012/28629, 2012, A1, . Location in patent: Page/Page column 27
[17] Chemistry - A European Journal, 2012, vol. 18, # 16, p. 4859 - 4865
[18] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 11, p. 3615 - 3621
[19] Letters in Organic Chemistry, 2012, vol. 9, # 2, p. 114 - 117
[20] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5282 - 5292
[21] Patent: WO2014/121291, 2014, A2, . Location in patent: Page/Page column 44; 45
[22] Tetrahedron Letters, 2016, vol. 57, # 48, p. 5301 - 5303
  • 12
  • [ 50-85-1 ]
  • [ 74-88-4 ]
  • [ 4670-56-8 ]
Reference: [1] Synthetic Communications, 2005, vol. 35, # 1, p. 145 - 152
[2] Journal of Chemical Research, Miniprint, 1997, # 1, p. 228 - 240
[3] Patent: EP2119718, 2009, A1, . Location in patent: Page/Page column 36
[4] Patent: WO2011/119549, 2011, A1, . Location in patent: Page/Page column 117-118
[5] Proceedings of the National Academy of Sciences of the United States of America, 2011, vol. 108, # 17, p. 6709 - 6714
  • 13
  • [ 50-85-1 ]
  • [ 4670-56-8 ]
YieldReaction ConditionsOperation in experiment
90% With sulfuric acid In methanol; ethyl acetate Methyl 4-Methylsalicylate
4-Methylsalicylic acid (100 g, 658 mmoles) was dissolved in anhydrous methanol (500 mL) and concentrated sulfuric acid (25 mL) was added carefully.
The solution was refluxed for 18 hours, then cooled to room temperature.
The reaction mixture was concentrated to about 150 mL, and ethyl acetate (250 mL) was added.
The ethyl acetate solution was washed twice with saturated aqueous sodium bicarbonate (250 mL portions) and thenwith saturated aqueous sodium chloride (100 mL).
The ethyl acetate solutionwas dried over anhydrous sodium sulfate, filtered, and evaporated to a clear, reddish-brown liquid.
This crude product was vacuum distilled (oil pump) to afford a clear, viscous liquid that solidified on standing to afford 98.1 g (90percent yield) of methyl 4-methylsalicylate.
1 H NMR (300 MHz, CHCl3 -d) δ2.32 (singlet, 3H, ArCH3), 3.91 (singlet, 3H, OCH3), 6.67 (doublet,J=8 Hz, 1H, ArH), 6.78 (singlet, 1H, ArH), 7.69 (doublet, J=8 Hz, 1H, ArH), 10.71 (singlet, 1H, OH).
13 C NMR (75 MHz, CHCl3 d) δ21.8, 52.1,110.0, 117.9, 120.6, 129.9, 147.3, 161.9, 170.9.
Reference: [1] Patent: US5744627, 1998, A,
  • 14
  • [ 7664-93-9 ]
  • [ 50-85-1 ]
  • [ 4670-56-8 ]
Reference: [1] Patent: US5965741, 1999, A,
  • 15
  • [ 50-85-1 ]
  • [ 4670-56-8 ]
YieldReaction ConditionsOperation in experiment
94% With ethereal hydrochloric acid In methanol (i)
methyl 4-methylsalicylate
To a suspension of 10 g (0.0651 mol) of 4-methylsalicylic acid in 150 mL of methanol was added 50 mL of ethereal hydrochloric acid.
The reaction mixture was heated at 60° C. for 60 hours.
The solvent was removed under vacuum.
After adding hexane-ethyl acetate, the resulting solid was filtered and the filtrate was evaporated to give 10.2 g (94percent) of product as an oil.
Reference: [1] Patent: US5185351, 1993, A,
  • 16
  • [ 67-56-1 ]
  • [ 50-85-1 ]
  • [ 18107-18-1 ]
  • [ 4670-56-8 ]
Reference: [1] Patent: WO2007/67613, 2007, A1, . Location in patent: Page/Page column 84
  • 17
  • [ 50-85-1 ]
  • [ 18107-18-1 ]
  • [ 4670-56-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 24, p. 8541 - 8554
  • 18
  • [ 50-85-1 ]
  • [ 149-73-5 ]
  • [ 4670-56-8 ]
Reference: [1] Tetrahedron Asymmetry, 1991, vol. 2, # 7, p. 481 - 494
[2] Tetrahedron Letters, 1991, vol. 32, # 8, p. 1055 - 1058
  • 19
  • [ 56-23-5 ]
  • [ 108-39-4 ]
  • [ 50-85-1 ]
  • [ 578-39-2 ]
Reference: [1] Chemische Berichte, 1879, vol. 12, p. 818,821
[2] Chemische Berichte, 1879, vol. 12, p. 818,821
  • 20
  • [ 56-23-5 ]
  • [ 108-39-4 ]
  • [ 50-85-1 ]
  • [ 578-39-2 ]
Reference: [1] Chemische Berichte, 1879, vol. 12, p. 818,821
  • 21
  • [ 50-85-1 ]
  • [ 74733-27-0 ]
Reference: [1] Patent: US6265416, 2001, B1,
[2] Patent: WO2013/186692, 2013, A1,
[3] Patent: WO2015/120390, 2015, A1,
[4] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 2, p. 185 - 190
[5] Patent: EP2272835, 2011, A1,
  • 22
  • [ 50-85-1 ]
  • [ 74-88-4 ]
  • [ 74733-27-0 ]
Reference: [1] Patent: US6359136, 2002, B1, . Location in patent: Example 1C
  • 23
  • [ 50-85-1 ]
  • [ 6623-35-4 ]
YieldReaction ConditionsOperation in experiment
89% With bromine In methanol at -20 - 20℃; for 1.5 h; To a mixture of 2-hydroxy-4-methylbenzoic acid (24.5 g, 161 mmol) in methanol (300 mL) was added dropwise a solution of bromine (28 g, 180 mmol) in methanol (50 mL) at -20 °C and the reaction mixture was stirred for 0.5 h, then warmed to rt and stirred for another 1 h. The reaction was quenched with saturated aquous sodium sulfite (100 mL). The reaction mixture was concentrated to remove methanol and the residue was diluted with water (50 mL).The mixture was filtered and the filtrate was dried to give a red-brown solid (33 g, 89 percent).MS (ESI, pos. ion) m/z: 231.1 [M+H]t
6.78 g With bromine In acetic acid at 10 - 35℃; for 5.5 h; A) 5-bromo-2-hydroxy-4-methylbenzoic acid To a solution of 2-hydroxy-4-methylbenzoic acid (5.00 g) in acetic acid (70.0 mL) was added dropwise bromine (1.68 mL) , and the mixture was stirred at room temperature for 5.5 hr. To the reaction mixture was added water, and the precipitate was collected by filtration, and dried under reduced pressure to give the title compound (6.78 g) . MS: [M-H]+ 229.0.
126 g at 10 - 35℃; To a mixture of 2-hydroxy-4-methylbenzoic acid (100 g) and acetic acid (1100 mL) was added dropwise bromine (34 mL) at room temperature, and the mixture was stirred at roomtemperature overnight. Water (800 mL) was added thereto, and the mixture was stirred at room temperature for 30 min. The precipitates were collected by filtration and washed with water to give the title compound (126 g) .MS: [M-H]~228.9, 230.9.
Reference: [1] Patent: WO2018/24224, 2018, A1, . Location in patent: Page/Page column 80; 81
[2] Patent: US2018/127370, 2018, A1, . Location in patent: Paragraph 0892
[3] Journal of the Chemical Society, 1914, vol. 105, p. 1891
[4] Journal fuer Praktische Chemie (Leipzig), 1915, vol. <2> 91, p. 388
[5] Patent: EP1391451, 2004, A1, . Location in patent: Page 84
[6] Patent: WO2015/163485, 2015, A1, . Location in patent: Paragraph 0349
[7] Patent: WO2016/208775, 2016, A1, . Location in patent: Paragraph 0393
  • 24
  • [ 56-23-5 ]
  • [ 50-85-1 ]
  • [ 6623-35-4 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1915, vol. <2> 91, p. 388
  • 25
  • [ 50-85-1 ]
  • [ 64-19-7 ]
  • [ 6623-35-4 ]
  • [ 6623-36-5 ]
Reference: [1] Journal of the Chemical Society, 1914, vol. 105, p. 1891
  • 26
  • [ 50-85-1 ]
  • [ 7732-18-5 ]
  • [ 64-19-7 ]
  • [ 4619-74-3 ]
  • [ 29666-53-3 ]
  • [ 6623-35-4 ]
  • [ 6623-36-5 ]
Reference: [1] Journal of the Chemical Society, 1914, vol. 105, p. 1891
  • 27
  • [ 74-96-4 ]
  • [ 50-85-1 ]
  • [ 88709-17-5 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In dimethyl sulfoxide at 35 - 40℃; for 11 h; Potassium carbonate (68.0 g, 0.492 mole) was added to a well-stirred solution of 4-methylsalicylic acid (25 g, 0.164 mole) in dimethylsulfoxide (75 ml ). The mixture was stirred at 35-40° C. and 1st lot of ethyl bromide (27.0 g, 0.247 mole) was added slowly over a period of 30 minutes then stirred for two hours and a second lot of ethyl bromide (27.0 g, 0.247 mole) was added over a period of 30 minutes at 35-40° C. The reaction mixture was further stirred at 35-40° C. for eight hours, cooled to 20-25° C., and diluted with dichloromethane (50 ml). The inorganics were removed by filtration and washed with dichloromethane. The combined filtrate and washings were diluted with water (50 ml), stirred for 30 minutes, and the organic layer was separated. The aqueous layer was further extracted with dichloromethane and the combined dichloromethane layer was washed with water (2.x.50 ml). The solvent was removed under vacuum to afford ethyl 2-ethoxy-4-methylbenzoate 34.2 g (quantitative yield).
88% With potassium carbonate In dimethyl sulfoxide at 40℃; for 10.5 h; To a mixture of 2-hydroxy-4-methylbenzoic acid (20.0 g, 131.5 mmol) and K2CO3 (54.5 g, 394.5 mmol) in DMSO (50 mL) at 40 °C was added bromoethane (21 .5 g, 197.2 mmol) over 30 minutes. The reaction was then stirred at 40 C for 2 hours. Further bromoethane (21.5 g, 197.2 mmol) was then added dropwise and the reaction stirred at 40 °C for 8 hours. DCM (200 mL) was added and the mixture was filtered. The organic layer was washed with water (4 x 150 mL), dried (Na2SO.i) and concentrated to give the title compound (24.1 g, 88percent) as a clear oil. LCMS-C: RT 2.77 min; m/z 209.1 [M+H] +
Reference: [1] Patent: US6686497, 2004, B1, . Location in patent: Page column 3-4
[2] Organic Process Research and Development, 2002, vol. 6, # 2, p. 184 - 186
[3] Patent: WO2016/34673, 2016, A1, . Location in patent: Page/Page column 103
[4] Journal of Medicinal Chemistry, 1998, vol. 41, # 26, p. 5219 - 5246
  • 28
  • [ 50-85-1 ]
  • [ 75-03-6 ]
  • [ 88709-17-5 ]
YieldReaction ConditionsOperation in experiment
90% With potassium carbonate In dimethyl sulfoxide at 40℃; for 11 h; To a mixture of 2-hydroxy-4-methylbenzoic acid (8.2 g, 54 mmol) and K2CO3 (22.4 g, 162 mmol) in DMSO (70 mL) at 40 C was added ethyl iodide (12.6 g, 80.8 mmol) drop-wise over a period of 30 minutes. The reaction was stirred for 2 hours then further ethyl iodide (12.6 g, 80.8 mmol) was added over 30 minutes. The resulting mixture was stirred for another 8 hours at 40 C, then diluted with DCM (150 mL) and filtered. The filtrate was washed with water (200 mL χ 10) and brine (200 mL 2), dried ( a2S04) and concentrated to give the desired compound (10.1 g, 90percent yield) as a yellow liquid. LCMS-C: RT 2.70 min; m/z 209.1 [M+H]*
90% With potassium carbonate In dimethyl sulfoxide at 40℃; for 11 h; To a mixture of 2-hydroxy-4-methylbenzoic acid (8.2 g, 53.9 mmol) and K2CO3 (22.4 g, 161.7 mmol) in dimethylsulfoxide (70 mL) at 40 ^C was added and ethyl iodide (12.6 g, 80.8 mmol) dropwise over a period of 30 min. The reaction was stirred for 2 h then further ethyl iodide (12.6 g, 80.8 mmol) was added over 30 min. The resulting mixture was stirred a further 8 h at 40 ^C, then diluted with CH2Cl2 (150 mL) and filtered. The filtrate was washed with water (200 mL x 10) and brine (200 mL x 2), dried (Na2SO4) and concentrated to give the desired compound as a yellow liquid (10.1 g, 90percent): LCMS: RT 2.70min; m/z 209.1 [M+H]+.
90% With potassium carbonate In dimethyl sulfoxide at 40℃; for 11 h; To a mixture of 2-hydroxy-4-methylbenzoic acid (8.2 g, 53.9 mmol) and K2CO3 (22.4 g, 161 .7 mmol) in dimethylsulfoxide (70 mL) at 40 °C was added ethyl iodide (12.6 g, 80.8 mmol) dropwise over a period of 30 min. The reaction was stirred for 2 hours then further ethyl iodide (12.6 g, 80.8 mmol) was added over 30 min. The resulting mixture was stirred a further 8 hours at 40 °C, diluted with CH2CI2 CI 5O mL) and filtered. The filtrate was washed with water (200 mL x 10) and brine (200 mL x 2), dried (Na2SC>4), filtered and concentrated to give the desired compound as a yellow liquid (10.1 g, 90percent): LCMS: RT 2.70min; m/z 209.1 [M+H]+.
85% With potassium carbonate In acetone at 20℃; for 72 h; [00463] Intermediate 48: Synthesis of ethyl 2-ethoxy-4-formylbenzoate[00464] Step 1: Synthesis of ethyl 2-ethoxy-4-methylbenzoate: To a mixture of 2- hydroxy-4-methylbenzoic acid (5.0 g, 32.9 mmol), K2C03 (18.9 g, 136.6 mmol) and acetone (50 mL) was added ethyl iodide (41.0 g, 263.2 mmol). The mixture was stirred at room temperature for 3 days. After filtration, the organic layer was concentrated to afford ethyl 2- ethoxy-4-methylbenzoate as colorless oil (5.7 g, 85percent), which was used directly for next step.

Reference: [1] Patent: WO2016/34673, 2016, A1, . Location in patent: Page/Page column 88; 89
[2] Patent: WO2017/153513, 2017, A1, . Location in patent: Page/Page column 72
[3] Patent: WO2017/153519, 2017, A1, . Location in patent: Page/Page column 63; 64
[4] Patent: WO2011/38204, 2011, A1, . Location in patent: Page/Page column 150
  • 29
  • [ 64-67-5 ]
  • [ 50-85-1 ]
  • [ 88709-17-5 ]
YieldReaction ConditionsOperation in experiment
94.11% With potassium carbonate In toluene at 25 - 45℃; for 21 - 31.5 h; Heating / reflux Added 260 ml (3.0 mol) of diethyl sulfate to the mixture of 1000 ml of toluene, 272.5 g (3.0 mol) of potassium carbonate and 100 g (1.0 mol) of 2-Hydroxy-4-methyl-benzoic acid at 25-45° C. for 1 hr to 1 hr 30 min. Heated the reaction mass to azeotropic reflux for 20-30 hr. Cooled the reaction mixture to 25-35° C. and collected the unwanted material by filtration, washed the unwanted material with 500 ml of toluene. Combined filtrate was washed with water (1.x.1000 ml and 1.x.500 ml) at 80-85° C. Total organic layer was concentrated to residue under vacuum at below 70° C. The yield of the title compound is 128 g (94.11percent). [0036] The obtained product was characterised by analytical techniques like IR, Mass and 1H-NMR
87% With potassium carbonate In acetonitrile for 12 h; Heating / reflux 4-Methyl salicylic acid (5 g, 32.89 mmol), diethyl sulfate (20.26 g, 0.131 mole) and anhydrous potassium carbonate (18.15 g, 0.132 mole) were mixed thoroughly in dry acetonitrile and mixture was refluxed for 12 hr. Reaction mixture was cooled and filtered through Celite bed. Filtrate was concentrated under vacuum. Residue was purified by fractional distillation at 0.5 mm vacuum. 1st fraction dis tilled at 48-51 C. (oil bath temperature 80 C.). Product (ethyl-2-ethoxy-4-methylbenzoate) 3 distilled at 90-93 C. (oil bath temperature 120 C.) Yield=6 g (87percent).
84% With potassium carbonate In 1,4-dioxane for 16 h; Heating / reflux 4-Methyl salicylic acid (5 g, 32.89 mmol), diethyl sulfate (20.26 g, 0.131 mole) and anhydrous potassium carbonate (18.15 g, 0.132 mole) were mixed thoroughly in dry dioxane and mixture was refluxed for 16 hr. Reaction mixture was cooled and filtered through Celite bed. Filtrate was concentrated under vacuum. Residue was purified by fractional distillation at 0.5 mm vacuum. 1st fraction dis tilled at 48-51 C. (oil bath temperature 80 C.). Product (ethyl-2-ethoxy-4-methylbenzoate) 3 distilled at 90-93 C. (oil bath temperature 120 C.) Yield=5.8 g (84percent).
75% With potassium carbonate In acetone for 16 h; Heating / reflux 4-Methyl salicylic acid (5 g, 32.89 mmol), diethyl sulfate (20.26 g, 0.131 mole) and anhydrous potassium carbonate (18.15 g, 0.132 mole) were mixed thoroughly in dry acetone and mixture was refluxed for 16 hr. Reaction mixture was cooled and filtered through Celite bed. Filtrate was concentrated under vacuum. Residue was purified by fractional distillation at 0.5 mm vacuum. 1st fraction dis tilled at 48-51 C. (oil bath temperature 80 C.). Product (ethyl-2-ethoxy-4-methylbenzoate) 3 distilled at 90-93 C. (oil bath temperature 120 C.) Yield=5.2 g (75percent)

Reference: [1] Patent: US2004/249188, 2004, A1, . Location in patent: Page 2; 3; 5
[2] Patent: US2004/192955, 2004, A1, . Location in patent: Page 3
[3] Patent: US2004/192955, 2004, A1, . Location in patent: Page 3
[4] Patent: US2004/192955, 2004, A1, . Location in patent: Page 3
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 50-85-1 ]

Repaglinide Related Intermediates

Chemical Structure| 88709-17-5

[ 88709-17-5 ]

Ethyl 2-ethoxy-4-methylbenzoate

Related Functional Groups of
[ 50-85-1 ]

Aryls

Chemical Structure| 83-30-7

[ 83-30-7 ]

2,4,6-Trihydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 71989-93-0

[ 71989-93-0 ]

2,4,6-Trihydroxybenzoic acid hydrate

Similarity: 0.93

Chemical Structure| 303-07-1

[ 303-07-1 ]

2,6-Dihydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 19829-74-4

[ 19829-74-4 ]

4,6-Dihydroxyisophthalic acid

Similarity: 0.93

Chemical Structure| 99-10-5

[ 99-10-5 ]

3,5-Dihydroxybenzoic acid

Similarity: 0.93

Carboxylic Acids

Chemical Structure| 83-30-7

[ 83-30-7 ]

2,4,6-Trihydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 71989-93-0

[ 71989-93-0 ]

2,4,6-Trihydroxybenzoic acid hydrate

Similarity: 0.93

Chemical Structure| 303-07-1

[ 303-07-1 ]

2,6-Dihydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 19829-74-4

[ 19829-74-4 ]

4,6-Dihydroxyisophthalic acid

Similarity: 0.93

Chemical Structure| 99-10-5

[ 99-10-5 ]

3,5-Dihydroxybenzoic acid

Similarity: 0.93